Why Govx fall down

The decline in GeoVax Labs' stock (GOVX) can be attributed to several factors:

1. Market Reaction to the Offering: The company's recent registered direct offering priced below the market, which could have led to a perception of undervaluation among investors. The offering was priced at $5 per share, while the stock had been trading significantly higher at around $8.33. This discrepancy could have triggered a sell-off among investors who believed the stock was overvalued post-offering.
2. Impact of the Mpox Outbreak: While the confirmation of a mpox case in Michigan's Wayne County initially caused a spike in the stock price, the overall market reaction may have been mixed. The emergence of a new clade of mpox and the potential public health implications could have stirred both optimism about GeoVax's potential role in the response and concern about the broader health crisis.
3. Short Interest and Market Volatility: GeoVax Labs has faced significant short interest, with short interest sitting at about 50% of float. This indicates that a substantial portion of the market has taken a bearish stance on the stock. Any negative news or market volatility could trigger a wave of short squeezes or forced liquidations, further exacerbating the stock's decline.
4. Financial Performance and Market Sentiment: The company's financial performance, including its gross proceeds from the offering, and market sentiment towards its future prospects, including the potential for a public health emergency, could have influenced investor decisions.

In conclusion, the decline in GeoVax Labs' stock can be attributed to a combination of factors including the company's registered direct offering priced below the market, the impact of the mpox outbreak, significant short interest, and the overall market sentiment towards the company's financial performance and future prospects.